You are here Home Resources and guidance Sponsors Moderna Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type (-) Designation or determination (3) Australian public assessment report (AusPar) (12) ARTG (11) Prescription medicine registration (8) Prescription medicine decision summary (4) Cancellation by sponsor (2) Prescription medicine evaluation (2) Date 2023 (1) 2022 (1) 2021 (1) Search Filters applied:Designation or determinationClear all Sponsor content3 result(s) found, displaying 1 to 3 Notice for mRNA-1345 (for Respiratory Syncytial Virus (RSV) pre-fusion F protein (Moderna Australia Pty Ltd) 30 March 2023 Designation or determination Priority review Notice for elasomeran and davesomeran (Moderna Australia Pty Ltd) 28 September 2022 Designation or determination Provisional determination Notice for elasomeran (Moderna Australia Pty Ltd) 24 June 2021 Designation or determination Provisional approval
Notice for mRNA-1345 (for Respiratory Syncytial Virus (RSV) pre-fusion F protein (Moderna Australia Pty Ltd) 30 March 2023 Designation or determination Priority review
Notice for elasomeran and davesomeran (Moderna Australia Pty Ltd) 28 September 2022 Designation or determination Provisional determination
Notice for elasomeran (Moderna Australia Pty Ltd) 24 June 2021 Designation or determination Provisional approval